I really like the technicals of this stock, we have nice over sold conditions with huge volume coming to accumulate. There is a huge gap above and I have set my targets on $6, $13 and $18 respectively. This is a larger time frame and potentially could take time to play out. I have attached an article below for you to reference the fundamentals. Not financial...
FGEN has been uptrending for two weeks. In November's earnings it beat on revenue and
burned less cash than projected. Another earnings report is impending. On the 30 minute
chart, price has pumped 250%. The volume is okay but is not showing a rise and the price
volume trend is flat. This is an unusual pattern. The mass index indicator shows hints of
...
Triple split screen analysis.
LEFT SCREEN:
FGEN broke support at $16.30 (white) and $9.20 (yellow) levels.
Currently it's at 47 cents and in what I refer to as, "no man's land."
It's "no man's land" because there's no support below it to keep price from falling further.
Could price reverse? Sure it could.
If price does reverse, it would retest 95 cent first...
Hi all.
Just an idea, not financial advice. :)
Looks like the FiboGen has reached its lowest level so far and to go 0 is not much left :)
seen the previous highs I think it is a good investment at the moment, with a low risk/high profit ratio in the long term, don't expect this to shoot up in a straight line in a week's time XD
downside, maybe backtest the...
The stock broke through resistance and went to close the gap. The global target is $24. Upside +50%. Trade with a trailing stop.
❤️ If you find this helpful and want more FREE forecasts in TradingView
. . . . . Please show your support back,
. . . . . . . . Hit the 👍 LIKE button,
. . . . . . . . . . . Drop some feedback below in the comment!
❤️ Your Support is...
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with...
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with...
Hey my friends, FIBROGEN is in a fake bearish push with a return of buy volume made and a large hammer candle upside down. In the TIMEFRAME M1 we oberved a marubozu with a low volume of sales issued it leaves on its last precedent lower. Who sits on the basis of the bollinger make his swallow to return to these levels and tests the high of the bollinger. In order...
FGEN: FibroGen, Inc
2018-12-20 07:00:00
FibroGen Announces Positive Topline Results from Three Global Phase 3 Trials of Roxadustat for Treatment of Anemia in Patients with Chronic Kidney Disease
